Gene · 5376
Papers3,310
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,310
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Video head impulse test findings in patients with peripheral myelin protein 22 related neuropathies. | Clin Neurophysiol | 2025 | 40334527 | PubTator, text mining | PubMed |
| Exploring the key technologies and applications of 6G wireless communication network. | iScience | 2025 | 40276774 | PubTator, text mining | PubMed |
| Ferroptosis and Charcot-Marie-Tooth Disease 1A: Emerging Evidence for a Pathogenic Association. | Antioxidants (Basel) | 2025 | 40227266 | PubTator, text mining | PubMed |
| A cross-sectional survey on the health status of patients with Charcot-Marie-Tooth disease in a Chinese national patient group. | J Neurol | 2025 | 40198420 | PubTator, text mining | PubMed |
| Segmented linear integral correlation Kernel ensemble reconstruction: A new method for climate reconstructions with applications to Holocene era proxies from an East Antarctic ice core. | PLoS One | 2025 | 40173401 | PubTator, text mining | PubMed |
| Nonrecurrent 17p duplications in two patients with developmental and neurological abnormalities. | Hum Genome Var | 2025 | 40140366 | PubTator, text mining | PubMed |
| Repeated clear benefits of immunotherapy in a patient with Charcot-Marie-Tooth disease carrying a rare point mutation in PMP22. | Neurogenetics | 2025 | 40126701 | PubTator, text mining | PubMed |
| A case report of a MODY6 patient coexistence with Charcot-Marie-Toothe 1A syndrome. | Front Endocrinol (Lausanne) | 2025 | 40026692 | PubTator, text mining | PubMed |
| Charcot-Marie-Tooth disease: a review of clinical developments and its management - What's new in 2025? | Expert Rev Neurother | 2025 | 40014417 | PubTator, text mining | PubMed |
| Genetic landscape of Charcot-Marie-Tooth disease in Vietnam: A prospective multicenter study. | J Neuromuscul Dis | 2025 | 39973457 | PubTator, text mining | PubMed |
| EMP2 promotes hepatocellular carcinoma proliferation and invasion by activating cellular autophagy. | Oncol Res | 2025 | 39866225 | PubTator, text mining | PubMed |
| Therapeutic potential of siRNA PMP22-SQ nanoparticles for Charcot-Marie-Tooth 1A neuropathy in rodents and non-human primates. | Int J Pharm | 2025 | 39855282 | PubTator, text mining | PubMed |
| Myelin Methods: A Mini-Review. | Toxicol Pathol | 2025 | 39829055 | PubTator, text mining | PubMed |
| Phosphodiesterase 4D inhibition improves the functional and molecular outcome in a mouse and human model of Charcot Marie Tooth disease 1 A. | Biomed Pharmacother | 2025 | 39823724 | PubTator, text mining | PubMed |
| Prioritization of causal genes from genome-wide association studies by Bayesian data integration across loci. | PLoS Comput Biol | 2025 | 39774334 | PubTator, text mining | PubMed |
| Direct percutaneous puncture of occluded venous stents as an adjunctive technique to restore patency. | CVIR Endovasc | 2025 | 39751748 | PubTator, text mining | PubMed |
| Identification of common diagnostic genes and molecular pathways in endometriosis and systemic lupus erythematosus by machine learning approach and in vitro experiment. | Int J Med Sci | 2025 | 39744159 | PubTator, text mining | PubMed |
| The neurological damage caused by enterovirus 71 infection is associated with hsa_circ_0069335/miR-29b/PMP22 pathway. | J Virol | 2025 | 39636111 | PubTator, text mining | PubMed |
| N6-Methyladenosine Modification of PERP by RBM15 Enhances the Tumorigenesis of Lung Adenocarcinoma via p53 Signaling Pathway. | Mol Biotechnol | 2025 | 39556280 | PubTator, text mining | PubMed |
| Ultrasonographic manifestations of Charcot-Marie-Tooth disease due to a mutation in the PMP22 gene: A case image. | J Clin Ultrasound | 2025 | 39282721 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5376/papers?page=6